The start-up medical device company Surgical Innovation Associates (SIA) recently announced their first product to achieve FDA clearance, and it’s one that will be of high interest to healthcare professionals who have been watching the ongoing debate around surgical mesh.
Read MoreBiomedical engineers have demonstrated that, by injecting an elastic biomaterial made from ordered and disordered proteins, a scaffold can form that responds to temperature and easily integrates into tissue.
Read MoreTraditional cigarette smoking has been implicated by indisputable physiologic and clinical evidence to have substantial wound healing problems in surgical procedures. Physiologically, nicotine and the thousands of chemicals in cigarette smoke induce not only peripheral vasoconstriction but also oxidative stress that weakens neutrophil function and subsequently wound healing through a variety of mechanisms.
Read MoreU.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has published in the scientific literature that it has successfully used autologous stem cells from fat tissue to repair decubitus ulcers.
Read MoreAn Iranian knowledge-based company has used marine animals’ waste to develop powerful healing agents for the treatment of various types of wound. There are many constituents in the biological cycle of organisms that can be used to treat humans.
Read MoreOxStem, an Oxford University spin-out developing regenerative medicine-based therapies, is launching two subsidiary companies to develop regenerative treatments for diabetes and chronic inflammation and wound healing.
Read MoreStudies of high-risk patients with peripheral artery disease or critical limb ischemia and those with complicated disease states are some of the late-breaking clinical trials that have been selected for presentation at VIVA.18 from Nov. 5 to 8 in Las Vegas.
Read MoreTrainer Suresh Kumar, who was once involved in first-aid work, used to think that wound caring meant washing the wound, cleaning it with antiseptic and applying a plaster. He later realised wound management is much more than that because lives and limbs can be saved when medical staff are well trained in this skill.
Read MoreAVITA Medical, a global regenerative medicine company, today announced that the U.S. Food and Drug Administration (FDA) approved the Company’s Premarket Approval (PMA) application to market the RECELL® Autologous Cell Harvesting Device (RECELL® System) to treat severe thermal burns in patients 18 years and older.
Read MoreThe Food and Drug Administration (FDA) has approved the Eluvia Drug-Eluting Vascular Stent System (Boston Scientific) for the treatment of peripheral artery disease. The Eluvia stent is designed to release paclitaxel for a 1-year time frame to prevent tissue regrowth that might otherwise block the stented artery.
Read More